QR kód

Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG 1 for recurrent glioblastoma

Abstract Background Glioblastoma (GB) is the most common and aggressive primary malignant brain tumor in adults. To date, no effective treatment has been reported for recurrent GB (rGB). Long noncoding RNA taurine upregulated gene 1 (TUG1), which is highly expressed in GB, resolves the formation of...

Celý popis

Uloženo v:
Hlavní autoři: Shoichi Deguchi, Fumiharu Ohka, Yoshiki Shiba, Junya Yamaguchi, Aya Sato, Keiko Shinjo, Yoshiki Arakawa, Yoshitaka Narita, Yutaka Kondo, Ryuta Saito
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2025-02-01
Edice:BMC Cancer
Témata:
Recurrent glioblastoma
TUG1
TUGIASO
Long noncoding RNA
On-line přístup:https://doi.org/10.1186/s12885-025-13623-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky